Murray B E
University of Texas Medical School, Houston.
Infect Dis Clin North Am. 1989 Sep;3(3):423-39.
Despite mankind's continuing efforts to find better and more powerful antimicrobial agents, bacteria continue to find ways to resist these agents. Recent examples include the emergence of plasmid-mediated resistance to third generation cephalosporins in E. coli, K. pneumoniae and Salmonella; the emergence of plasmid-mediated beta-lactamase in E. faecalis; the appearance of ciprofloxacin resistance among methicillin-resistant staphylococci; and, perhaps most threatening, the appearance of vancomycin resistance in E. faecalis and E. faecium, at least some of which is plasmid mediated. These examples demonstrate the continuing need for studies of resistance and for new compounds, and the need for new stategies in managing bacterial infections.
尽管人类不断努力寻找更好、更强效的抗菌剂,但细菌仍能找到抵抗这些药物的方法。近期的例子包括,大肠杆菌、肺炎克雷伯菌和沙门氏菌中出现了质粒介导的对第三代头孢菌素的耐药性;粪肠球菌中出现了质粒介导的β-内酰胺酶;耐甲氧西林葡萄球菌中出现了对环丙沙星的耐药性;也许最具威胁性的是,粪肠球菌和屎肠球菌中出现了万古霉素耐药性,其中至少部分是由质粒介导的。这些例子表明,持续开展耐药性研究和研发新化合物仍然很有必要,同时也需要采用新策略来管理细菌感染。